121 related articles for article (PubMed ID: 11016474)
1. The role of telomerase in breast cancer.
Mokbel K
Eur J Surg Oncol; 2000 Aug; 26(5):509-14. PubMed ID: 11016474
[No Abstract] [Full Text] [Related]
2. Telomerase activity in normal and neoplastic breast.
Tsao Jl; Zhao Y; Lukas J; Yang X; Shah A; Press M; Shibata D
Clin Cancer Res; 1997 Apr; 3(4):627-31. PubMed ID: 9815730
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
[TBL] [Abstract][Full Text] [Related]
4. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
6. [Telomerase activity in infiltration ductal carcinoma of breast].
Wu S; Liu Z; Sun H
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):515-6. PubMed ID: 10923461
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].
Song M; Li BL; Mi XY; Gao YX; Song JY
Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037
[TBL] [Abstract][Full Text] [Related]
8. [Significance of telomerase expression in diagnosis and treatment of breast tumor].
Qiu XG; Liu YP; Pu QT; Gu QH; Han JJ
Ai Zheng; 2002 Nov; 21(11):1241-3. PubMed ID: 12526225
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables.
Kalogeraki A; Kafousi M; Ieromonachou P; Giannikaki E; Vrekoussis T; Zoras O; Tsiftsis D; Stathopoulos E
Anticancer Res; 2005; 25(3B):1927-30. PubMed ID: 16158927
[TBL] [Abstract][Full Text] [Related]
10. Telomerase and breast cancer: from diagnosis to therapy.
Mokbel K; Williams NJ
Int J Surg Investig; 2000; 2(1):85-8. PubMed ID: 12774343
[TBL] [Abstract][Full Text] [Related]
11. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
15. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells.
Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V
J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
Maxhimer JB; Pesce CE; Stewart RA; Gattuso P; Prinz RA; Xu X
J Am Coll Surg; 2005 Mar; 200(3):328-35. PubMed ID: 15737842
[TBL] [Abstract][Full Text] [Related]
17. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
18. Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients.
Rha SY; Jeung HC; Park KH; Kim JJ; Chung HC
Oncol Res; 2009; 18(5-6):213-20. PubMed ID: 20225759
[TBL] [Abstract][Full Text] [Related]
19. Expression of human delta-6-desaturase is associated with aggressiveness of human breast cancer.
Lane J; Mansel RE; Jiang WG
Int J Mol Med; 2003 Aug; 12(2):253-7. PubMed ID: 12851727
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Mueller C; Riese U; Kosmehl H; Dahse R; Claussen U; Ernst G
Int J Oncol; 2002 Feb; 20(2):385-90. PubMed ID: 11788906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
